Brugger, W., & Thomas, M. (2012). EGFR-TKI resistant non-small cell lung cancer (NSCLC): New developments and implications for future treatment. Lung cancer, 77(1), . https://doi.org/10.1016/j.lungcan.2011.12.014
Chicago Style (17th ed.) CitationBrugger, Wolfram, and Michael Thomas. "EGFR-TKI Resistant Non-small Cell Lung Cancer (NSCLC): New Developments and Implications for Future Treatment." Lung Cancer 77, no. 1 (2012). https://doi.org/10.1016/j.lungcan.2011.12.014.
MLA (9th ed.) CitationBrugger, Wolfram, and Michael Thomas. "EGFR-TKI Resistant Non-small Cell Lung Cancer (NSCLC): New Developments and Implications for Future Treatment." Lung Cancer, vol. 77, no. 1, 2012, https://doi.org/10.1016/j.lungcan.2011.12.014.
Warning: These citations may not always be 100% accurate.